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At a Glance Commentary:  
Scientific Knowledge on the Subject: Older individuals with obstructive sleep apnea are at risk 
of presenting cognitive decline and dementia. While previous studies investigated cerebral gray 
matter structure in obstructive sleep apnea, inconsistencies exist regarding the presence of 
changes and their specific locations in the brain. Furthermore, there is a lack of understanding 
regarding gray matter integrity in the aging population with obstructive sleep apnea since very 
few studies specifically evaluated this age group.  
 
What This Study Adds to the Field: This study assessed the relationship between intrinsic 
markers of obstructive sleep apnea severity and multiple measures of cerebral gray matter 
structure in a large sample of middle-aged and older individuals. We found that the main markers 
of obstructive sleep apnea severity are related to increased thickness and/or volume of the frontal, 
parietal, and cingulate regions of the cortex as well as the amygdala. These results suggest that 
obstructive sleep apnea in the aging and mostly presymptomatic population is associated with 
underlying cerebral adaptive/reactive mechanisms.  
 
This article has an online data supplement, which is accessible from this issue's table of content 
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Abstract  
 
Rationale: Obstructive sleep apnea causes intermittent hypoxemia, hemodynamic fluctuations, 
and sleep fragmentation, all of which could damage cerebral gray matter that can be indirectly 
assessed with neuroimaging. 
Objectives: To investigate whether markers of obstructive sleep apnea severity are associated 
with gray matter changes among middle-aged and older individuals.  
Methods: Seventy-one subjects (ages: 55 to 76; apnea–hypopnea index: 0.2 to 96.6 events/h) 
were evaluated with magnetic resonance imaging. Two techniques were used: 1) voxel-based 
morphometry, which measures gray matter volume and concentration; 2) FreeSurfer automated 
segmentation, which estimates the volume of predefined cortical/subcortical regions and cortical 
thickness. Regression analyses were performed between gray matter characteristics and markers 
of obstructive sleep apnea severity (hypoxemia, respiratory disturbances, sleep fragmentation). 
Measurements and Main Results: Subjects had few symptoms, i.e. sleepiness, depression, 
anxiety and cognitive deficits. While no association was found with voxel-based morphometry, 
FreeSurfer revealed increased gray matter with obstructive sleep apnea. Higher levels of 
hypoxemia correlated with increased volume and thickness of the left lateral prefrontal cortex as 
well as increased thickness of the right frontal pole, the right lateral parietal lobules, and the left 
posterior cingulate cortex. Respiratory disturbances positively correlated with right amygdala 
volume while more severe sleep fragmentation was associated with increased thickness of the 
inferior frontal gyrus. 
Conclusions: Gray matter hypertrophy and thickening were associated with hypoxemia, 
respiratory disturbances, and sleep fragmentation. These structural changes in a group of middle-
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aged and older individuals may represent adaptive/reactive brain mechanisms attributed to a 
presymptomatic stage of obstructive sleep apnea. 
Keywords: Sleep-Disordered Breathing, Aging, Neuroimaging, Hypoxemia, Cerebral Cortex. 
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Main text  
Introduction  
 
Repetitive airway collapses in obstructive sleep apnea (OSA) lead to chronic cycles of 
hypoxemia/reoxygenation and hypercapnia, hemodynamic fluctuations, and sleep fragmentation 
(1). According to animal models, these pathophysiological processes have consequences on the 
brain by provoking oxidative stress, cellular death and cellular morphological modifications (2-
4). Consequently, OSA may lead to structural cerebral gray matter changes. Considering that 
OSA is particularly common in the aging population (1) and is a risk factor for accelerated 
cognitive decline (5) and dementia (6), the relation between gray matter integrity and OSA 
severity in the older population must be assessed to deepen our understanding of its contribution 
to neurodegeneration. 
In OSA, gray matter volume has been investigated predominantly in middle-aged adults 
using voxel-based morphometry (VBM). A recent meta-analysis showed that OSA correlates 
with a smaller parahippocampal and fronto-temporal cortex (7). However, due to variations 
between studies (e.g. VBM pipeline, apnea-hypopnea index [AHI] thresholds), others argue that 
there is currently no clear evidence of gray matter atrophy (8).  
Since the sole use of VBM resulted in inconsistencies, its combination with alternative 
morphometric techniques could lead to a clearer picture of gray matter integrity in OSA. Few 
studies used other analysis techniques and gray matter characteristics. Regional cortical thinning 
and reduced gray matter concentration were reported in middle-aged individuals with OSA (9, 
10). Moreover, segmentation of predefined subcortical structures in OSA individuals showed 
gray matter atrophy (hippocampi, mammillary bodies, caudate nuclei) (11-13) but also 
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hypertrophy (hippocampi, putamen) (14, 15).  
It is unclear whether OSA leads to altered structural gray matter integrity. This is especially 
true in the older population with OSA for whom gray matter integrity has not been assessed 
thoroughly. The present study focuses on late middle-aged and older individuals, and investigates 
the association between OSA severity and gray matter characteristics estimated with different 
analysis techniques: volume and concentration measured with VBM; and cortical thickness and 
cortical/subcortical volume assessed with FreeSurfer automated segmentation. Instead of groups 
based on an arbitrary criterion to define OSA, we used a regression approach on a large sample 
with varying levels of OSA severity. The novelty of the study resides in the fact that it combines 
multiple analysis techniques and gray matter characteristics in association with multiple markers 
of OSA severity (hypoxemia, respiratory disturbances, and sleep fragmentation).  
We hypothesized that all markers of OSA severity, but more particularly hypoxemia, would 
be linked to reduced gray matter in regions known to be sensitive to pathological processes 
observed in OSA (e.g. hippocampus and surrounding structures, prefrontal cortex) (1). We also 
hypothesized that an alternative method to VBM, namely FreeSurfer automated segmentation, 
could be more sensitive to reveal how OSA affects specific brain regions. Preliminary results 
have been previously reported in abstract form (16). 
 
Methods  
 An online supplement describes the protocol in detail. The study included 71 subjects who 
were either healthy controls or newly diagnosed and untreated individuals with OSA. Thirty-
seven of them (52%) participated in a previous study on cerebral perfusion in OSA (17). Ten 
subjects were recruited from a clinic for suspected OSA while the remaining subjects were 
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recruited through newspapers advertisements. Exclusion criteria were neurological, pulmonary, 
and major psychiatric diseases; sleep disorders other than OSA; OSA treatment including 
continuous positive airway pressure; uncontrolled diabetes and hypertension; morbid obesity; and 
medication affecting cerebral functioning. The Ethics Committees (#2012-697 and #12-13-008) 
approved the research protocol and written consent was obtained from each subject. 
Subjects were evaluated with an all-night in-laboratory polysomnographic recording and 
3-Tesla magnetic resonance imaging (MRI). Although the AHI is generally thought to represent 
OSA severity, its sole use has been challenged (18). Indeed, other variables related to oxygen 
saturation and sleep quality are also recognized as correlates of OSA severity. A principal 
component analysis was therefore used to extract independent markers of OSA severity, to 
reduce the number of statistical tests, and to prevent the multi-collinearity problem of highly 
correlated variables in a regression. Respiratory and sleep variables that strongly correlated with 
the AHI (p <0.001) were included in the principal component analysis. Although less-correlated 
variables could be of interest, they may not fully reflect OSA pathophysiology and are not as well 
suited for a principal component analysis. Resulting rotated and uncorrelated components 
represented hypoxemia, respiratory disturbances, and sleep fragmentation (see Table 1).  
Figure 1 depicts the neuroimaging analysis techniques used, i.e., VBM and FreeSurfer 
automated segmentation. VBM was performed in accordance with published recommendations 
(8). T1-weighted MRI images were processed with the VBM8 toolbox (http://www.neuro.uni-
jena.de/) within SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). Default processing 
options were used to run the pipeline, including a spatial normalization that deformed every 
subject into a common space. The pipeline was run once with and once without modulation, 
which rescales images and transforms gray matter concentration into volume (19). A multiple 
regression design within SPM8 was performed between markers of OSA severity (hypoxemia, 
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respiratory disturbances, and sleep fragmentation) and both gray matter volume and 
concentration, adjusted for age, sex, body mass index, and intracranial volume. Level of 
significance was set at p <0.05, clusters corrected for multiple comparisons with topological 
false-discovery rate.  
MRI images were also processed using FreeSurfer (http://surfer.nmr.mgh.harvard.edu/), 
which features the volumetric segmentation of subcortical structures (20) and the parcellation of 
the cortical surface (21) without a deforming spatial normalization. Cortical/subcortical volume 
and cortical thickness values from predefined brain regions were extracted for each subject. 
Hierarchical linear regressions for extracted FreeSurfer values were performed with age, sex, 
body mass index, and intracranial volume as covariates (Step 1) and with markers of OSA 
severity (hypoxemia, respiratory disturbances, and sleep fragmentation; Step 2). Level of 
significance was set at p <0.01 for R2 changes, i.e., the increase in variance explained by adding 




1. Clinical characteristics of the sample 
Seventy-eight subjects were evaluated with an MRI. A neuroradiologist inspected the MRI 
images, which led to the exclusion of six subjects for major abnormalities such as silent infarcts 
or large arachnoid cysts. Another subject was excluded due to a processing problem, for a total of 
seven exclusions after the MRI.  
The final sample was composed of 71 subjects ranging in age from 55 to 76 (mean age: 
65.3 ± 5.6 years). Although the objective of the study was answered with a regression design 
  7 
across the complete sample, subjects were divided into four groups based on their AHI and one-
way ANOVAs were performed to better characterize our sample’ characteristics (see Table 2). 
Healthy control subjects (AHI <5) represented 17% of the sample, 42% were included in the mild 
OSA group (AHI between ≥5 and <15), 16% were included in the moderate OSA group (AHI 
between ≥15 and <30), and 25% were individuals considered to have severe OSA (AHI ≥30). 
The AHI varied from 0.2 to 96.6 events/h and 35% of the final sample had an OSA-related 
complaint and/or had suspected OSA before joining the study (e.g., snoring, daytime sleepiness, 
lack of energy, bed partner witnessing respiratory disturbances).  
Groups were statistically comparable for the Epworth Sleepiness Scale, the Beck 
Depression and Anxiety Inventories, the Montreal Cognitive Assessment, the Mini-Mental State 
Examination, and the Index of Vascular Burden (see Table 2). Markers of OSA severity extracted 
with the principal component analysis (see Table 1) did not correlate with any of these 
questionnaires and tests. In fact, a minority of mild to severe OSA subjects had excessive 
daytime sleepiness (33% with Epworth Sleepiness ≥10), depressive symptoms (26% with Beck 
Depression Inventory II ≥10), anxiety symptoms (12% with Beck Anxiety Inventory ≥10) and 
cognitive deficits (16% with Montreal Cognitive Assessment <26). In summary, this suggests 
that our participants were not highly symptomatic in terms of sleepiness, mood, and global 
cognition, and that this symptomatology was not related to OSA severity. Moreover, a minority 
of OSA subjects was obese (25% with a body mass index ≥30 kg/m2) or had more than one 
cardiovascular risk factor and disease (31% with an Index of Vascular Burden >1).  
2. Gray matter hypertrophy and thickening with OSA severity 
VBM revealed no significant association between OSA severity and clusters of gray matter 
volume or concentration at a false-discovery rate corrected threshold (p <0.05).  
Conversely, with FreeSurfer automated segmentation, significant regression models 
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revealed increases, but no decrease, in cortical thickness and volume associated with markers of 
OSA severity (see Table 3, Figure 2, and Figure E1 of the online supplement). The majority of 
significant models were of increased cortical thickness in relation to the level of hypoxemia. 
More severe hypoxemia was associated with increased thickness of the left rostral middle frontal 
gyrus, the right frontal pole, the right superior and inferior parietal lobules, and the left posterior 
cingulate cortex. Hypoxemia levels were also positively correlated with the volume of the left 
pars orbitalis portion of the inferior frontal gyrus. Moreover, higher levels of respiratory 
disturbances were associated with a hypertrophic right amygdala whereas an increased level of 
sleep fragmentation was correlated with a thicker pars triangularis region of the right inferior 
frontal gyrus.  
3. Complementary results of gray matter hypertrophy and thickening with OSA severity 
Interestingly, similar positive associations were observed at a trend level with FreeSurfer 
(R2 change between p <0.05 and p >0.01; predicting OSA components p <0.01;  values between 
0.24 and 0.40) for contralateral cortical regions in relation to hypoxemia levels (thickness of the 
right rostral middle frontal gyrus, left inferior parietal lobule, and right posterior cingulate cortex) 
as well as for subcortical regions in association with more respiratory disturbances (volume of the 
left amygdala, hippocampus, and thalamus). 
To assess whether gray matter structure is associated with markers of OSA severity even in 
milder forms of OSA, analyses were conducted among control subjects and mild to moderate 
groups (AHI <30). With FreeSurfer, increased gray matter was found in relation to hypoxemia in 
several fronto-parietal regions and respiratory disturbances in left thalamus and precuneus (see 
online supplement).  
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Discussion 
This study investigated the association between markers of OSA severity and gray matter 
integrity in untreated individuals aged 55 and over. We found that higher levels of hypoxemia 
during sleep were associated with increased volume and/or thickness of the prefrontal, parietal, 
and cingulate regions of the cortex. Moreover, a higher number of respiratory disturbances was 
associated with an enlarged amygdala whereas a more fragmented sleep was correlated to a 
thicker frontal cortex. Our hypothesis was only partially confirmed since we predicted that 
atrophied gray matter would be associated with increased OSA severity. The novelty of this study 
lies not only in its results, but also in the use of specific markers of OSA severity in relation with 
multiple cerebral gray matter characteristics.  
1. Potential mechanisms underlying gray matter increases with OSA severity  
It would be surprising that gray matter increases underlie better neuron viability or 
neurogenesis. Indeed, neurogenesis in the adult brain is less probable outside the hippocampus, 
the subventricular zone and the olfactory bulb (22). Gray matter hypertrophy and thickening may 
instead result from cerebral edema, a well-known effect of hypoxemia that can be observed after 
only 16 h in protocols imitating altitude in humans (23). Consistently, a diffusion MRI study in 
individuals with newly diagnosed OSA suggested the presence of vasogenic edema in subcortical 
structures (24). In addition to edema, hypoxia causes changes in cellular size or quantity with the 
potential to enlarged gray matter. In fact, studies on rodents subjected to intermittent hypoxia 
during their sleep (1 to 10 days and 5 weeks respectively) showed increased brain water content, 
branching of surviving neurons, as well as astroglial hyperplasia and/or hypertrophy (i.e., reactive 
gliosis) (3, 25). Increased gray matter in relation to hypoxemia levels could also be representative 
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of early neurodegeneration processes. Multiple animal models of hypoxic exposure (from few 
hours to several days) consistently showed increased -amyloid generation (1), a pathogenic 
mechanism of Alzheimer’s disease. -amyloid deposition in the absence of abnormal tau levels 
was recently reported to correlate with increased cortical thickness (26). 
Overall, intermittent hypoxemia is probably a key mechanism leading to cerebral edema, 
cellular responses and early neurodegeneration in gray matter. This is consistent with our 
findings since most regions with increased gray matter were associated with hypoxemia levels. 
Similarly, hypoxemia strongly correlated with gray matter increases even when subjects with 
severe OSA were removed from the analysis, confirming that milder forms of OSA are also 
associated with gray matter changes in our sample. At the clinical level, it suggests that 
intermittent hypoxemia may be particularly important to consider when making decision for 
treatment, even in patients with AHI below 30. 
In addition to the relationship between hypoxemia and gray matter characteristics, 
respiratory disturbances and sleep fragmentation were also associated with gray matter 
hypertrophy or thickening in the present study. Changes in breathing pattern due to obstructions 
and sleep fragmentation were shown to be both independently associated with blood pressure 
fluctuations (27, 28), which could lead to cerebral edema (29). Furthermore, experimental 
obstructive apneas and sleep fragmentation may distinctly provoke cellular responses through 
various mechanisms, such as cerebral oxidative stress (2, 4). However, the specific effects of 
respiratory disturbances and sleep fragmentation are less understood than the effects of 
intermittent hypoxemia. 
2. Increases versus decreases of gray matter structure in OSA 
Although the existing literature mostly reports gray matter losses among individuals with 
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OSA (7-13), gray matter hypertrophy has also been observed (14, 15, 30-32). The same pattern is 
shown with the effect of OSA treatment on gray matter. In one set of studies, treatment led to 
gray matter hypertrophy, suggesting a recovery from atrophic processes (33, 34), while others 
showed that OSA treatment reduced either regional gray matter or whole brain volume (31, 35), 
suggesting reversal of hypertrophic processes such as brain edema.  
Increased gray matter may represent a presymptomatic stage of the OSA disease process 
where its severity is characterized by reactive and adaptive brain mechanisms, such as cerebral 
edema, reactive gliosis, neuronal branching, and increased -amyloid deposition. Later in the 
disease progression, gray matter atrophy could represent predominantly neuronal damage due to 
chronic OSA and lead to cognitive decline. Both adaptive and maladaptive effects on the brain 
have consistently been described for processes that follow cycles of airway obstructions and 
reoxygenation (36). Our sample had low levels of symptoms, namely sleepiness, mood and 
cognitive deficits, which reflect that most subjects were in a presymptomatic stage of OSA that 
may be characterized by more adaptive brain responses and thus, increased gray matter. 
Obviously, these hypotheses must be confirmed.   
OSA duration might affect the balance between adaptive and maladaptive mechanisms, but 
it is generally unknown. In hypoxic rodent and human protocols that observed mechanisms that 
could underlie increased gray matter, exposure to hypoxia was relatively short (from a few hours 
to several days) (1, 3, 23, 25). Gray matter hypertrophy and thickening could therefore be present 
in an earlier stage of the disease, although duration of hypoxic exposure in rodent and human 
protocols is difficult to translate to OSA in a clinical setting. 
 Age could also determine whether atrophy or hypertrophy is observed in reaction to OSA. 
In fact, OSA in older adults is possibly different in terms of mechanisms, comorbidities, 
consequences, and symptoms compared to younger patients. Age is associated with partially 
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protective mechanisms against OSA, such as reduced production of oxidative stress following 
apneas (37) and decreased blood pressure and heart rate responses following arousals (38). 
Adaptive effects of hypoxia on the brain could lead to relative cerebrovascular protection and 
reduced mortality risk in subjects over age 50 with OSA compared to their younger counterparts 
(39). Therefore, a different response to OSA could occur with age and its severity may be 
correlated with increases in gray matter structure. Very few studies have specifically evaluated 
gray matter in subjects over age 50. These had very different designs and objectives, and thus, 
diverging results (40-42). Therefore, how OSA impacts the aging brain must be clarified. 
3. Vulnerability of specific brain regions to OSA 
In the present study, markers of OSA severity were associated with increased thickness or 
volume in the lateral prefrontal cortex, the parietal lobules, and posterior cingulate cortex as well 
as the amygdala. Interestingly, previous studies on OSA showed both increased and decreased 
gray matter volume and/or thickness in the same or adjacent regions as those reported in the 
present study (9, 11, 13-15, 30-32, 43, 44). Therefore, these regions may be especially vulnerable 
to OSA and be preferentially affected by both swelling and atrophic processes. It is also 
important to highlight that we found trends for association between OSA markers of severity and 
increased gray matter in contralateral brain regions. It would be interesting to follow this cohort 
in order to verify whether these trends will reach significance over time.   
 Hypoxemia and sleep fragmentation correlated with the structure of the lateral prefrontal 
cortex in our study. It has been suggested that the prefrontal cortex is vulnerable to both 
hypoxemia and sleep disruption in OSA (45). In addition, our results showed that hypoxemia was 
associated with core constituents of the default mode network, namely the parietal and posterior 
cingulate regions of the cortex. The metabolic activity of these highly connected regions 
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fluctuates together (46) and their elevated oxygen demand could make them more vulnerable to 
hypoxemia (47). Finally, we found that amygdala volume was linked to respiratory disturbances, 
which is consistent with its altered activity during a respiratory challenge in OSA subjects (48).  
4. Utility of complementary gray matter analysis techniques and characteristics 
While the most widely used technique for gray matter analysis is VBM, we observed no 
changes with this method, a result supported by previous studies on OSA (35, 49). VBM has 
limitations including misregistration and reduced accuracy of region location (19). This might be 
exacerbated by ventricular expansion caused by global atrophy in normal aging, in which 
processing errors could lead to false results in regions surrounding the ventricles. FreeSurfer 
automated segmentation may be more sensitive in detecting early changes in OSA than a voxel-
based approach, since volume and thickness are computed by region without a prior spatial 
normalization. Instead, the brain is labeled and segmented in an automated manner similar to 
manual volumetry (20, 21), which probably represent more closely the real structure. However, 
FreeSurfer automated segmentation is time-consuming and depends on predefined atlases.  
VBM and FreeSurfer segmentation show results on different scales. While VBM 
investigates the brain voxel by voxel (1.5 mm3), the predefined regions extracted with FreeSurfer 
are much larger. This suggests that increases in gray matter with OSA severity are subtle and 
diffuse across a given brain structure, which could have been missed in some previous VBM 
studies. In addition, more regions of increased thickness than volume were observed with 
FreeSurfer, a result that may also have been missed with VBM. Overall, FreeSurfer automated 
segmentation and its measurement of cortical thickness seems to be more sensitive to detect gray 
matter increases with OSA severity than VBM. However, our results must be replicated by 
further studies in the older population with OSA.  
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5. Strengths and limitations 
Our large sample size of 71 subjects with an AHI varying from 0.2 to 96.6 events/h 
represent the entire spectrum of OSA severity, which allowed a regression approach. This 
eliminated the need for an arbitrary criterion to define the presence of the condition that is 
necessary for a between-group design, leading to inconsistencies between studies. A regression 
design also allowed us to investigate different markers of OSA severity. Moreover, the use of 
different analysis techniques and gray matter characteristics yielded a more complete evaluation 
of gray matter in OSA. 
Nonetheless, the fact that most of our subjects were not severely hypoxic (see Table 2) and 
were mostly presymptomatic restricts the generalization of our results to other individuals with 
OSA. Although our strict exclusion criteria facilitate the interpretation of our findings by 
excluding many confounding conditions, they could limit the generalization of our results to 
individuals presenting OSA and comorbidities.  
Although we included sex as a nuisance covariate, women with OSA may present more 
maladaptive than adaptive cerebral processes. In fact, compared to males with comparable OSA 
severity, females have impaired white matter integrity (50). Since we investigated only 16 
females (23% of our sample), this could explain the difference between our results and the study 
by Celle et al. (40), which showed brainstem atrophy among mostly women (64%) in a similar 
age group. 
6. Conclusions 
Our study revealed that markers of OSA severity, i.e. hypoxemia, respiratory disturbances, 
and sleep fragmentation, are linked to increases in cortical thickness and gray matter volume that 
are more sensitively detected with a technique alternative to VBM, namely FreeSurfer automated 
segmentation. OSA severity, especially hypoxemia, could contribute to gray matter hypertrophy 
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and thickening through local edema and reactive cellular responses. These structural changes in 
frontal, parietal, and cingulate regions of the cortex and in the amygdala may be possible in 
presymptomatic and/or older subjects with OSA, among whom more adaptive than maladaptive 
mechanisms may occur. Longitudinal investigations are needed to determine whether increased 
gray matter structure will later show atrophy and be associated with cognitive decline in order to 
deepen our understanding of the link between OSA and neurodegeneration in the aging 
population.  
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Figure 1. Processing steps for estimating gray matter characteristics using VBM (A) and 
FreeSurfer (B). T1-weighted MRI images were used for both VBM and FreeSurfer analyses. In 
order to conduct VBM analyses (A), images were first segmented and normalized into a common 
space. A non-linear modulation was performed to obtain volume and final volume and 
concentration images were smoothed. In summary, the VBM processing pipeline segments and 
deforms gray matter to allow inter-subject comparisons for both gray matter concentration and 
volume in every voxel. For FreeSurfer analyses (B), non-brain tissues were first removed and a 
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registration was performed. The brain was segmented according to voxel intensities and a 
probabilistic atlas to extract subcortical volumes. White- and gray matter boundaries were traced 
and the cortex was parcelled and labeled based on folding pattern and a probabilistic atlas. Thus, 
FreeSurfer outputs are undeformed cortical/subcortical volume as well as cortical thickness of 
regions predefined by built-in atlases. Overall, both analysis techniques work differently to 
estimate gray matter characteristics: with VBM, the brain was deformed and gray matter was 
compare at each voxel. With FreeSurfer automated segmentation, gray matter values are 
averaged over regions labeled in the undeformed brain according to built-in atlases. VBM images 
and FreeSurfer extracted values correspond to final processed variables used in multiple 
regression analyses with markers of OSA severity. FWHM, full-width half maximum; MRI, 
magnetic resonance imaging; VBM, voxel-based morphometry; OSA, obstructive sleep apnea. 
 
 
Figure 2. Locations of increased gray matter estimated with FreeSurfer automated 
segmentation in association with markers of OSA severity. Hypoxemia [1] was positively 
correlated with the volume of the left pars orbitalis of the inferior frontal gyrus and the thickness 
of the left rostral middle frontal gyrus, the left posterior cingulate cortex, and the right frontal 
pole, as well as the right superior and inferior parietal lobules. Moreover, higher levels of 
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respiratory disturbances [2] were associated with a larger right amygdala while more severe sleep 
fragmentation [3] was correlated with an increased thickness of the right pars triangularis of the 
inferior frontal gyrus. Regression analyses included age, sex, body mass index, and intracranial 
volume as nuisance covariates. OSA, obstructive sleep apnea. 
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Footnotes 
Footnotes for Table 1.  
Bold variables show how variable loads on each rotated component. Loadings >0.5 were 
considered to be variables that contribute the most to the component. OSA, obstructive sleep 
apnea; SpO2, oxygen saturation; TST, total sleep time; NREM1, non-rapid eye movement sleep 
stage 1. 
 
Footnotes for Table 2.  
Results are presented as mean (standard deviation). OSA, obstructive sleep apnea; AHI, apnea–
hypopnea index; F, females; TST, total sleep time; SpO2, oxygen saturation; NREM1, non-rapid 
eye movement sleep stage 1. * X2 tests were performed between groups; † p <0.05; ‡ p <0.001. 
 
Footnotes for Table 3.  
Bold variables show the predicting OSA component for each region of increased gray matter. 
OSA, obstructive sleep apnea; BMI, body mass index; ICV, intracranial volume; ΔR2; R2 change; 
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Tables 
Table 1. Markers of OSA severity obtained with a principal component analysis of respiratory 
and sleep variables.  






Minimal SpO2 (%) -0.867 -0.330 -0.188 
TST with SpO2 <90% (min) 0.815 0.408 0.175 
Apnea‒Hypopnea Index (events/h) 0.389 0.877 0.221 
TST in apnea‒hypopnea (%) 0.401 0.852 0.265 
Micro-arousal index (events/h) -0.002 0.404 0.816 
Number of stage transitions to NREM1 and wakefulness 0.437 0.050 0.803 
Accounted variance (%) 32.0% 32.3% 24.9% 
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Table 2. Clinical and polysomnographic characteristics of healthy control, mild, moderate and 
severe OSA groups.  
Variables 






AHI ≥5 to <15 
Moderate  
OSA (C) 







Number of subjects n = 12 n = 30 n = 11 n = 18   
Sex* (#F; %F) 2F; 16.7% 10F; 33.3% 1F; 9.1% 3F; 16.7% 3.7  
Age (years) 62.3 (4.7) 65.8 (5.9) 65.9 (5.1) 66.1 (5.7) 1.4  
Body mass index (kg/m2) 26.5 (3.9) 26.5 (3.1) 27.9 (2.1) 28.7 (2.6) 2.6  
Epworth Sleepiness Scale 6.5 (4.8) 7.2 (4.8) 9.7 (4.8) 8.2 (4.6) 0.6  
Beck Depression Inventory 3.2 (3.7) 5.3 (4.9) 6.2 (5.2) 7.6 (5.9) 1.8  
Beck Anxiety Inventory 4.3 (5.3) 3.1 (3.3) 3.2 (4.5) 4.0 (4.1) 0.2  
Montreal Cognitive Assessment 27.4 (2.4) 27.5 (2.0) 27.5 (2.4) 26.9 (2.6) 0.3  
Mini-Mental State Examination 28.1 (2.3) 29.0 (1.0) 28.2 (1.8) 29.2 (1.0) 2.6  
Index of Vascular Burden 0.8 (0.8) 1.0 (1.1) 1.0 (0.9) 0.9 (0.8) 0.1  
% hypercholesterolemia* 25.0 36.7 36.4 44.4 1.2  
% hypertension* 41.7 40.0 54.6 39.0 0.8  
Respiratory variables    
AHI (events/h) 2.1 (1.5) 9.2 (2.5) 22.2 (4.8) 45.1 (19.5) 180.8‡ A <B <C <D 
TST in apnea–hypopnea (%) 1.2 (1.1) 5.7 (2.0) 12.8 (1.9) 31.5 (15.5) 147.8‡ A <B <C <D 
Mean SpO2 (%) 95.5 (0.6) 94.6 (1.2) 93.7 (0.7) 94.2 (1.2) 6.1† A >C, D 
Minimal SpO2 (%) 90.5 (3.3) 88.5 (3.3) 83.6 (3.8) 81.5 (5.9) 16.3‡ A, B >C, D  
TST with SpO2 <90% (min) 0.1 (0.1) 2.0 (5.7) 5.5 (3.8) 17.6 (18.6) 26.2‡ A, B <C, D 
Sleep variables    
TST (min) 369.2 (60.7) 341.5 (64.5) 370.9 (43.9) 368.5 (46.0) 1.4  
Wake duration (min) 100.8 (44.6) 101.3 (57.5) 80.2 (46.4) 91.6 (54.0) 0.6  
  30 
Sleep efficiency (%) 78.5 (9.0) 77.2 (12.6) 82.6 (9.1) 80.6 (10.0) 0.8  
Micro-arousal index (events/h) 12.0 (3.9) 14.3 (6.1) 14.3 (5.7) 25.2 (11.2) 8.8‡ A, B, C <D 
# of stage transitions to NREM1 
and wakefulness 
56.9 (19.2) 55.1 (15.0) 66.8 (19.0) 97.8 (41.8) 9.6‡ A, B <D 
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Table 3. Significant hierarchical linear regressions between markers of OSA severity and regions 





Age Sex BMI ICV  








Subcortical volume          
R amygdala 
R2 31.9%†     47.9%†    
ΔR2      16.0%†    
 -0.07 0.01 0.05 0.52† -0.06 0.39† 0.16 
Cortical volume          
L pars orbitalis 
(inferior frontal) 
R2 11.8%     30.0%†    
ΔR2     18.3%†    
 -0.03 0.05 -0.08 0.30 0.44† -0.02 -0.12 
Cortical thickness          
L rostral middle 
frontal gyrus 
R2 8.9%     29.4%†    
ΔR2     20.5%†    
 -0.24 -0.02 0.11 -0.23 0.47† 0.13 0.02 
R frontal pole 
R2 0.0%     19.1%    
ΔR2     18.8%†    




R2 6.5%     22.9%    
ΔR2     16.5%*    
 -0.16 0.11 0.18 -0.15 0.23 0.17 0.32* 
R superior 
parietal lobule 
R2 7.7%     24.3%    
ΔR2     16.7%*    
 -0.11 0.03 0.22 0.04 0.40† 0.17 0.09 
R inferior R2 3.8%     20.8%    
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parietal lobule ΔR2     17.0%*    
 -0.17 0.00 0.09 -0.08 0.43† 0.13 -0.08 
L posterior 
cingulate cortex 
R2 5.9%     23.7%    
ΔR2     17.8%†    
 -0.08 -0.18 0.15 -0.03 0.36† 0.29 0.08 
 
 
